Predictive value of [18F]FDG PET/CT and index lymph node response following neoadjuvant pembrolizumab in resectable stage 3 melanoma: Real world data from the largest melanoma centres in the Netherlands
European Journal of Cancer · 2026
DOI: 10.1016/j.ejca.2026.116691 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2026. Verfasst von Michael J Wilson und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Melanoma, Antibodies, Monoclonal, Humanized, Positron Emission Tomography Computed Tomography, Fluorodeoxyglucose F18. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
- Department of Surgical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.
- Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
- Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
- Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, the Netherlands.
- Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: a.kuijpers@nki.nl.
Zitieren
APA
Wilson, M. J., Schurink, A. W., Schrage, Y., Wouters, M. W. J. M., van Houdt, W. J., Grunhagen, D. J., van Thienen, H. V., van de Wiel, B. A., van der Hiel, B., & Kuijpers, A. M. J. (2026). Predictive value of [18F]FDG PET/CT and index lymph node response following neoadjuvant pembrolizumab in resectable stage 3 melanoma: Real world data from the largest melanoma centres in the Netherlands. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2026.116691
Vancouver
Wilson MJ, Schurink AW, Schrage Y, Wouters MWJM, van Houdt WJ, Grunhagen DJ, et al. Predictive value of [18F]FDG PET/CT and index lymph node response following neoadjuvant pembrolizumab in resectable stage 3 melanoma: Real world data from the largest melanoma centres in the Netherlands. European Journal of Cancer. 2026. doi:10.1016/j.ejca.2026.116691
BibTeX
@article{Wilson2026,
author = {Wilson, Michael J and Schurink, Antonius W and Schrage, Yvonne and Wouters, Michel W J M and van Houdt, Winan J and Grunhagen, Dirk J and van Thienen, Hans V and van de Wiel, Bart A and van der Hiel, Bernies and Kuijpers, Anke M J},
title = {Predictive value of [18F]FDG PET/CT and index lymph node response following neoadjuvant pembrolizumab in resectable stage 3 melanoma: Real world data from the largest melanoma centres in the Netherlands},
journal = {European Journal of Cancer},
year = {2026},
doi = {10.1016/j.ejca.2026.116691}
}
EUVIMED